Nektar Therapeutics
NKTR
#6155
Rank
A$1.34 B
Marketcap
A$66.21
Share price
2.25%
Change (1 day)
206.28%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are A$62.6 Million. In 2024 the company made an earning of -A$0.18 Billion, an increase over its 2023 earnings that were of -A$0.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion-0.91%
2024 -A$0.18 Billion-56.85%
2023 -A$0.42 Billion-24.31%
2022 -A$0.55 Billion-30.25%
2021 -A$0.78 Billion17.87%
2020 -A$0.67 Billion0.88%
2019 -A$0.66 Billion-164.46%
2018 A$1.01 B-810.61%
2017 -A$0.15 Billion-37.06%
2016 -A$0.23 Billion89.22%
2015 -A$0.13 Billion48.22%
2014 -A$81.06 Million-65.93%
2013 -A$0.24 Billion-6.81%
2012 -A$0.26 Billion28.95%
2011 -A$0.2 Billion258.8%
2010 -A$55.19 Million-63.94%
2009 -A$0.16 Billion-392.45%
2008 A$52.33 M-211.74%
2007 -A$46.84 Million-79.57%
2006 -A$0.23 Billion-16.9%
2005 -A$0.28 Billion81.53%
2004 -A$0.16 Billion54.19%
2003 -A$98.57 Million-33.87%
2002 -A$0.15 Billion-9.6%
2001 -A$0.17 Billion73.39%
2000 -A$95.09 Million108.9%
1999 -A$45.52 Million39.48%
1998 -A$32.64 Million60.02%
1997 -A$20.4 Million18.05%
1996 -A$17.28 Million31.82%
1995 -A$13.11 Million57.14%
1994 -A$8.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$12.27 B-7,345.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.64 B-10,516.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.38 B-20,393.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
A$0.22 M-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.49 B-11,604.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
-A$0.41 Billion 137.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A$0.60 B-456.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
A$48.24 B-28,571.74%๐Ÿ‡บ๐Ÿ‡ธ USA